Atmotuit 500mg Capsule
Product Info
| Prescription required | Yes |
| Marketer | Skiptuit Healthcare |
| Active Ingredient | Terbinafine (500mg) |
| Storage | Store below 30°C |
| Chemical Class | Allylamine |
| Habit Forming | No |
| Therapeutic Class | ANTI INFECTIVES |
| Action Class | Fungal ergosterol synthesis inhibitor |
| User Rating | 4.5 |
| User Reviews | 380 |
FAQ
Does Atmotuit 500mg cause any skin reactions?
Yes, sensitive individuals may develop skin reactions while using Atmotuit 500mg. There are rare reports of people developing serious skin/hypersensitivity reactions like Stevens-Johnson syndrome, toxic epidermal necrolysis, and other severe skin reactions with Atmotuit 500mg. Therefore, do not take this medication without consulting your physician. And, in case you encounter any type of skin reaction or rashes, stop the medication immediately and report to the doctor.
Can I drink tea or coffee while taking Atmotuit 500mg?
Caffeinated drinks like tea and coffee should be taken with caution while being on treatment with Atmotuit 500mg. Atmotuit 500mg decreases the rate of metabolism of caffeine by 19% which is an important constituent of coffee, thereby increasing the levels of caffeine in the blood. These increased levels of caffeine may lead to side effects such as jitteriness, headache, increased heartbeat, and restlessness.
How long do I need to take Atmotuit 500mg?
The usual duration of treatment for Tinea pedis (fungal infection in the foot), Tinea corporis (ringworms), and Tinea cruris (fungal infection in the groin) is about 2 to 4 weeks. The duration may sometimes be extended to 6 weeks. For fungal infections of nails, the duration of treatment usually varies from 6 to 12 weeks. For fingernail fungal infections it may take 6 weeks whereas toenail fungal infection may take about 12 weeks. However, the exact duration of the therapy is decided by the doctor depending upon the type of infection, the site of infection, and the patient’s response to the therapy.
Is Atmotuit 500mg effective?
Atmotuit 500mg is effective as an anti fungal medicine if used in the dose and duration advised by your doctor. Do not stop taking it even if you see improvement in your condition. If you stop taking this medicine too early, the fungus may continue to grow and the infection may return or worsen.
Can Atmotuit 500mg be safe for use in patients with liver cirrhosis?
Oral intake of Atmotuit 500mg is not recommended in patients with chronic or active liver disease. Your doctor may prescribe a liver function test to check whether the liver is functioning effectively or not. This is done because the medicine gets metabolized by liver enzymes and any inefficiency in liver function can lead to increased levels of the medication in the blood, resulting in increased side effects and toxicity. Therefore, it is important to inform your doctor if you have any liver disease or cirrhosis. Also, inform your doctor about the medicines you may be taking as taking Atmotuit 500mg with another medicine can lead to liver toxicity and Atmotuit 500mg by acting on the liver enzymes can change the levels of other drugs. Your doctor may suggest periodic monitoring (after 4-6 weeks of treatment) of liver function test and make dose adjustments accordingly.
What if you forget to take Atmotuit Capsule?
If you miss a dose of Atmotuit 500mg, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
Atmotuit 500mg Capsule Reviews
Atmotuit 500mg belongs to a group of medicines called antifungals It is used to treat a wide range of fungal infections of the skin and nails, including ringworm. It works by killing the fungi that cause the infection.
Atmotuit 500mg can be taken with or without food. You should take it regularly as prescribed by your doctor. Taking it at the same time every day will help you to remember to take it. The dose and duration of treatment will depend on what you are being treated for. Do not stop taking it until you have finished the complete course, even when you feel better. If you stop taking this medicine too early, the fungus may continue to grow and the infection may return or worsen.
This medicine's most common side effects include rash, headache, nausea, and abnormal liver enzyme. These are usually mild but let your doctor know if they bother you or last more than a few days.
Before using it, you should tell your doctor if you are allergic to any antibiotics or have any kidney or liver problems. You should also let your healthcare team know all other medicines you are taking as they may affect, or be affected by this medicine. Pregnant and breastfeeding mothers should consult their doctor before using it. Your doctor will monitor your liver function regularly during treatment.
How Atmotuit 500mg Capsule Works
Atmotuit 500mg is an antifungal medication. It kills and stops the growth of the fungi by destroying its cell membrane, thereby treating your skin infection.
How to Use Atmotuit 500mg Capsule
Take this medicine in the dose and duration as advised by your doctor. Atmotuit 500mg may be taken with or without food, but it is better to take it at a fixed time.Avoid Atmotuit 500mg with caffeine and chocolate as well as food containing caffeine and chocolate such as tea leaves, cocoa beans.
Benefits of Atmotuit 500mg Capsule
- In Fungal infections: Atmotuit 500mg is an antifungal medicine. It works by killing and stopping the growth of fungus causing the infection. The dose and duration of treatment will depend on what you are being treated for. Make sure you complete the full dose your doctor has prescribed. This will ensure that the infection is completely cured and prevent it from returning.
Uses of Atmotuit 500mg Capsule
- Fungal infections
Atmotuit 500mg Capsule Side Effects
Safety Tips
Kidney
CAUTION
Atmotuit 500mg should be used with caution in patients with kidney disease. Dose adjustment of Atmotuit 500mg may be needed. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
Atmotuit 500mg may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Alcohol
CAUTION
Caution is advised when consuming alcohol with Atmotuit 500mg. Please consult your doctor.
Liver
CAUTION
Atmotuit 500mg should be used with caution in patients with liver disease. Dose adjustment of Atmotuit 500mg may be needed. Please consult your doctor.
Driving
UNSAFE
Atmotuit 500mg may cause side effects which could affect your ability to drive.
Breast feeding
CONSULT YOUR DOCTOR
Atmotuit 500mg is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Quick Tips
- Inform your doctor if you are pregnant, planning to conceive or breastfeeding.
- Atmotuit 500mg helps treat fungal infections of the skin and nails.
- Treatment may be needed for 2 to 6 weeks for skin infections and 6 weeks to 6 months for nail infections.
- Your doctor may monitor your liver function regularly during treatment. Inform your doctor if you notice yellowing of eyes or skin, dark urine, or stomach pain.
- Do not skip any doses and finish the full course of treatment even if you feel better.
References
- Terbinafine hydrochloride [Prescribing Information]. East Hanover, New Jersey: Novartis Pharmaceuticals Corporation; 2012.
- Robertson DB, Maibach HI. Dermatologic Pharmacology. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. p. 1051, 1053.
- Mayo Clinic. Terbinafine.
- Bennett JE. Antifungal Agents. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. New York, New York: McGraw-Hill Medical; 2011. p. 1586, 1588.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. p. 1329.